Recent News

Share
and/or
24 News Items found
In the Clinic
Medical oncologist Jae Park
Longest-Running CAR T Trial Shows Which Patients Benefit Most, Have Fewest Side Effects
The study represents 20 years of research at MSK.
Announcement
Pediatric oncologist Kevin Curran with CAR T patient Esmeralda Pineda
FDA Approves First CAR T Cell Therapy for Leukemia
Children, teens, and young adults with leukemia that have stopped responding to chemotherapy are the first eligible to receive the new treatment.
In the Clinic
MSK medical oncologist Luis Diaz, Jr.
The Science Behind the FDA’s Approval of an Immunotherapy for Mismatch Repair–Deficient Cancers
A new paper from MSK physician-scientist Luis Diaz presents the evidence on which the FDA approved the immunotherapy drug pembrolizumab for cancers with a specific genetic abnormality.
In the News
American Society of Clinical Oncology logo
#ASCO17: Post-Conference Roundup of Themes and Trends
Read up on the progress being made in several key areas of cancer research, including immunotherapy, targeted therapy, precision surgery, and epigenetics.
In the Lab
CAR T cells attacking cancer
CRISPR Genome-Editing Tool Takes Cancer Immunotherapy to the Next Level
What do you get when you combine two of the hottest areas of biotechnology? A new paper from MSK researchers explains.
In the Lab
a sneaky man on a sneaky mission
Stealth Mode: How Metastatic Cancer Cells Evade Detection by the Immune System
Cancer cells have a sneaky ability to hide out in the body for years at a time. MSK scientists are looking for ways to flush them out.
In the Lab
photo of Foxo1 protein stained in regulatory T cells
In the Fight against Cancer, the Immune System Can Be a Double-Edged Sword
The immune system is a powerful tool for fighting cancer — sometimes too powerful.
In the Clinic
New treatments developed at MSK focus on both common and rare cancers.
Report Highlights Advances Made at MSK That Are Changing Patients’ Lives
An annual report from an influential cancer group highlights three MSK studies that have advanced cancer research.
Finding
Michel Sadelain and Prasad Adusumilli
Immunotherapy Shows Promise for Treating Solid Tumors in the Chest
A study in mouse models suggests how modified T cells may be used to treat tumors in the area just outside the lungs.
In the Lab
Pictured: Experimental Brain Tumor
Genetic “Kill Switch” Could Make Cell Therapies Safer
Researchers have engineered a gene into therapeutic cells that allows them to turn off tumor growth if some of the cells become cancerous.